Stay updated on IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The change is a minor site-wide version update from Revision: v3.4.1 to v3.4.2, affecting only the page footer and not study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-17T03:15:10.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A new history entry Revision: v3.4.1 was added and an older government funding notice was removed; these are administrative updates that do not change trial information.
    Difference
    0.7%
    Check dated 2026-02-09T22:43:30.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding, informing users that updates may be delayed and directing them to opm.gov for status updates.
    Difference
    0.7%
    Check dated 2026-02-02T20:43:32.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The history page now shows UI enhancements such as a glossary toggle and color-coded change highlights (green for additions and red for deletions), along with updated footer notes including Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1.0%
    Check dated 2026-01-26T19:40:50.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The history now shows Revision: v3.3.4 added and Revision: v3.3.3 removed.
    Difference
    0.1%
    Check dated 2026-01-19T13:47:12.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The page adds a new revision entry 'Revision: v3.3.3' and removes 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' from the footer/history section.
    Difference
    0.2%
    Check dated 2025-12-22T01:20:46.000Z thumbnail image

Stay in the know with updates to IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page.